연구성과로 돌아가기
2025 연구성과별 연구자 정보 (327 / 1187)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Lee, Jeong-Hoon | Lee, JH | 10 | Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Seoul, South Korea | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Park, Neung Hwa | Park, NH | 11 | limys@amc.seoul.kr; | ||||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Kwon, So Young | Kwon, SY | 12 | Konkuk Univ, Med Ctr, Seoul, South Korea | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Park, Soo Young | Park, SY | 13 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Daegu, South Korea | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Kim, Ji Hoon | Kim, JH | 14 | Korea Univ Guro Hosp, Guro Hosp, Seoul 152703, South Korea | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Choi, Gwang Hyeon | Choi, GH | 15 | Seoul Natl Univ, Natl Univ, Dept Pathol, Bundang Hosp, Seongnam, South Korea | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Jang, Eun Sun | Jang, ES | 16 | Seoul Natl Univ, Natl Univ, Dept Pathol, Bundang Hosp, Seongnam, South Korea | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Chen, Chien-Hung | Chen, CH | 17 | Kaohsiung Chang Gung Mem Hosp, Chang Gung Med Fdn, Kaohsiung, Taiwan | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Hsu, Yao-Chun | Hsu, YC | 18 | E Da Hosp, Kaohsiung, Taiwan | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Bair, Ming-Jong | Bair, MJ | 19 | Mackay Mem Hosp, New Taipei, Taiwan | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Cheng, Pin-Nan | Cheng, PN | 20 | Natl Cheng Kung Univ Hosp, Tainan, Taiwan | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Tung, Hung-Da | Tung, HD | 21 | Chi Mei Hosp Liouying, Liouying, Tainan County, Taiwan | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Chang, Te-Sheng | Chang, TS | 22 | Chia Yi Chang Gung Mem Hosp, Chiayi, Taiwan | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Lo, Ching-Chu | Lo, CC | 23 | St Martin De Porres Hosp, Chiayi, Taiwan | limys@amc.seoul.kr; | |||||
| Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION) interim results from a randomised controlled trial | Tseng, Kuo-chih | Tseng, KC | 24 | Dalin Tzu Chi Hosp, Chiayi, Taiwan | limys@amc.seoul.kr; |
페이지 이동: